Fig. 3
From: Chronic Lyme borreliosis associated with minimal change glomerular disease: a case report
Evolution of biologic and clinical parameters in response of therapeutic interventions. Left vertical axis: log scale. d0: diagnosis. d8: ACEi introduction. d21: Ceftriaxone introduction. d28: Corticosteroid (CS) introduction. d46: end of ceftriaxone therapy. d52: Start of the CS Tapering, 2.5 mg per week. d115: ceftriaxone re-introduction, CS 47.5 mg. d147: end of second ceftriaxone therapy. d178: CS 17.5 mg/day, tapering of 2.5 mg/15 days until 10 mg then 1 mg every month. d245: CS 9 mg. Note : conversion factor units : Serum creatinine in mg/dL to μmol/L x 88,4